
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated February 23, 2021, titled "Sun Pharma to introduce complete range of Brivaracetam at an affordable price for epilepsy treatment in India".
Filed with NSE ·

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated February 23, 2021, titled "Sun Pharma to introduce complete range of Brivaracetam at an affordable price for epilepsy treatment in India".
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries